| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense) | 15,664 | 24,819 | - | -4,530 |
| Income (loss) before income tax expense | 8,853 | - | - | -26,625 |
| Income tax expense (refund) | 26 | - | - | 69 |
| Net income (loss) | 8,827 | -11,654 | -24,691 | -26,694 |
| Attributable to non-controlling interests | 2,977 | -27,140 | -14,107 | -13,827 |
| Net income (loss) attributable to fortress | 5,850 | 15,486 | -10,584 | -12,867 |
| Preferred a dividends declared and paid and/or cumulated, and fortress' share of subsidiary deemed dividends | 2,174 | - | 2,131 | 2,173 |
| Net income (loss) attributable to common stockholders | 3,675 | - | -12,715 | -15,040 |
| Earnings per share, basic | 0.13 | 0.5 | -0.48 | -0.76 |
| Earnings per share, diluted | 0.11 | 0.45 | -0.48 | -0.76 |
| Weighted average number of shares outstanding, basic | 27,244,474 | 26,879,380 | 26,450,218 | 19,697,290 |
| Weighted average number of shares outstanding, diluted | 33,100,961 | 29,824,182 | 26,450,218 | 19,697,290 |
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)